PRESS RELEASE published on 10/23/2025 at 11:55, 10 months 18 days ago Informations privilégiées / Autres communiqués Arkema achève la décarbonation de son site de Lacq/Mourenx avec l'installation d'une unité de traitement des effluents soufrés plus performante. Ce projet s'inscrit dans une démarche d'économie circulaire et de réduction des émissions de gaz à effet de serre Décarbonation Économie Circulaire Émissions ARKEMA Lacq/Mourenx
PRESS RELEASE published on 10/23/2025 at 11:55, 10 months 18 days ago Inside Information / Other news releases Arkema completes decarbonization project at Lacq/Mourenx site, cutting down emissions and implementing circular economy approach Decarbonization Investment ARKEMA Lacq/Mourenx Specialty Sulfur Derivatives
PRESS RELEASE published on 10/03/2025 at 09:12, 11 months 8 days ago Inside Information / Other news releases Press release regarding total number of shares and voting rights in compliance with French commercial code and Financial Markets Authority regulations Voting Rights French Commercial Code Shares Financial Markets Authority Compliance
PRESS RELEASE published on 10/03/2025 at 09:12, 11 months 8 days ago Informations privilégiées / Autres communiqués Déclaration du nombre total de droits de vote et d'actions au 30/09/2025 conformément aux réglementations financières Autorité Des Marchés Financiers Déclaration Droits De Vote Actions Réglementé
BRIEF published on 10/03/2025 at 09:07, 11 months 8 days ago Arkema : Déclaration des Droits de Vote et d'Actions Autorité Des Marchés Financiers Droits De Vote Code De Commerce Actions ARKEMA
BRIEF published on 10/03/2025 at 09:07, 11 months 8 days ago Arkema: Declaration of Voting Rights and Shares Voting Rights Financial Markets Authority Actions ARKEMA Commercial Code
PRESS RELEASE published on 10/03/2025 at 09:02, 11 months 8 days ago Inside Information / Other news releases Press release regarding statement on number of shares and voting rights as per French commercial code and AMF regulations Voting Rights French Commercial Code Shares AMF Regulations Financial Markets
PRESS RELEASE published on 10/03/2025 at 09:02, 11 months 8 days ago Informations privilégiées / Autres communiqués Déclaration du nombre total de droits de vote et d’actions conformément aux réglementations de l'Autorité des Marchés Financiers Déclaration Droits De Vote Actions AMF Réglementé
BRIEF published on 08/26/2025 at 13:54, 1 year ago Arkema: Declaration of the Number of Voting Rights and Shares Voting Rights Treasury Shares Financial Transparency ARKEMA July 31, 2025
BRIEF published on 08/26/2025 at 13:54, 1 year ago Arkema : Déclaration du Nombre de Droits de Vote et d’Actions Droits De Vote Actions Auto-détenues Transparence Financière ARKEMA 31 Juillet 2025
Published on 09/11/2026 at 04:00, 7 hours 6 minutes ago Torq Announces Debt Settlement and Corporate Update
Published on 09/10/2026 at 22:25, 12 hours 41 minutes ago Pathfinder Ventures Announces Appointment of Mickey Perret as Chief Executive Officer
Published on 09/10/2026 at 15:20, 19 hours 46 minutes ago MicroVision to Preview Next-Generation Lidar-Based Perception Platform at IAA Transportation 2026
Published on 09/10/2026 at 15:00, 20 hours 6 minutes ago All Randomized Pediatric Patients to Continue in the Single-Blind Extension Phase of Jaguar Health's Pivotal Clinical Trial of Crofelemer for Microvillus Inclusion Disease (MVID) with Intestinal Failure (IF)
Published on 09/11/2026 at 10:15, 51 minutes ago TCMA Receives Two National Awards, Highlighting Thailand’s Cement Industry Progress Towards Net Zero 2050
Published on 09/11/2026 at 09:20, 1 hour 46 minutes ago Cantourage Expands Portfolio with New Cannabis Active Ingredients for Innovative Compounded Medicines
Published on 09/11/2026 at 09:05, 2 hours 1 minute ago ROHM's New High Anti-surge Chip Resistors in "SDR01 Series" Achieve 0.33W Rated Power in 0402 Size
Published on 09/11/2026 at 09:00, 2 hours 6 minutes ago Homann Holzwerkstoffe publishes its 2026 half-year report
Published on 09/11/2026 at 07:00, 4 hours 6 minutes ago BIOPHYTIS ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY
Published on 09/11/2026 at 07:00, 4 hours 6 minutes ago BIOPHYTIS ANNONCE LA RÉALISATION D’UNE AUGMENTATION DE CAPITAL DE 5,3 MILLIONS D’EUROS DESTINÉE À FINANCER SON ESSAI DE PHASE 2 DANS L’OBÉSITÉ
Published on 09/10/2026 at 19:30, 15 hours 36 minutes ago Availability of the 2026 Interim Financial Report
